Published in BMC Cancer on January 30, 2008
Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia (2009) 1.42
EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC. Mol Cancer Res (2013) 0.97
Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma. Mol Oncol (2015) 0.85
MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells. Cancer Res (2015) 0.83
Mononuclear phagocytes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2009) 0.79
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis. Int J Clin Exp Pathol (2014) 0.78
Expression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma. PLoS One (2011) 0.75
In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma. PLoS One (2015) 0.75
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer (2006) 5.60
The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer (2005) 5.07
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A (2000) 3.44
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol (2000) 3.39
IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol (2003) 3.26
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res (1999) 2.70
Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol (2005) 2.64
Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res (2007) 2.52
Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol (2005) 2.50
Interaction between tobacco and alcohol consumption and the risk of cancers of the upper aero-digestive tract in Brazil. Am J Epidemiol (1999) 2.49
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate (2006) 1.90
Regulation of the macrophage content of neoplasms by chemoattractants. Science (1983) 1.83
Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res (2005) 1.63
Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther (2006) 1.54
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol (2004) 1.31
Strategies of tumor immune evasion. BioDrugs (2005) 1.26
The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer (2001) 1.22
Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer (2001) 1.20
Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol (1999) 1.19
Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol (2003) 1.17
Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. Cancer Treat Res (2006) 1.14
IL-6: from laboratory to bedside. Clin Rev Allergy Immunol (2005) 1.13
Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Mol Pharmacol (2005) 1.11
Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. Anticancer Res (2003) 1.01
Tumor-associated macrophages: foe or accomplice of tumors? Anticancer Res (2003) 0.91
Monocytes, alcohol use, and altered immunity. Alcohol Clin Exp Res (1998) 0.89
Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma. Laryngoscope (2000) 0.87
Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J (2000) 0.87
Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Acta Otolaryngol (2006) 0.86
Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck (1994) 0.85
Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma. Cancer (2007) 0.83
Immunological aspects of head and neck cancer: biology, pathophysiology and therapeutic mechanisms. Surgeon (2004) 0.81
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density. Acta Otolaryngol (2005) 0.80
Ex vivo interleukin (IL)-1 beta, IL-6, IL-12 and tumor necrosis factor-alpha responsiveness with monocytes from patients with head and neck carcinoma. Eur Arch Otorhinolaryngol (1999) 0.80
Local injection of OK-432/fibrinogen gel into head and neck carcinomas. Eur J Cancer (1994) 0.80
A quantitative and qualitative study of blood monocytes in smokers. Eur J Respir Dis (1985) 0.79
In vitro T-lymphocyte function in head and neck cancer patients. Eur Arch Otorhinolaryngol (1997) 0.79
Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14-dependent pathway. Scand J Immunol (2001) 0.78
22. Immune responses to malignancies. J Allergy Clin Immunol (2003) 0.77
Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol (2007) 2.30
Continuous laryngoscopy exercise test: a method for visualizing laryngeal dysfunction during exercise. Laryngoscope (2006) 1.62
Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. J Infect Dis (2002) 1.48
Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol (2008) 1.39
[A four-year-old boy with swollen cheek after a fall]. Tidsskr Nor Laegeforen (2005) 1.39
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck (2010) 1.34
Human papillomavirus infections in laryngeal cancer. Head Neck (2011) 1.22
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
Anaesthesia in endoscopic sinus surgery. Eur Arch Otorhinolaryngol (2003) 1.02
Exercise-induced laryngeal obstruction: natural history and effect of surgical treatment. Eur Arch Otorhinolaryngol (2011) 0.98
Questionable necessity to remove the submandibular gland in neck dissection. Head Neck (2010) 0.94
Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol (2011) 0.93
Exercise induced dyspnea in the young. Larynx as the bottleneck of the airways. Respir Med (2009) 0.93
Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol (2002) 0.92
Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg (2013) 0.92
Audiovisual assessment of exercise-induced laryngeal obstruction: reliability and validity of observations. Eur Arch Otorhinolaryngol (2009) 0.91
Personality and choice of coping predict quality of life in head and neck cancer patients during follow-up. Acta Oncol (2008) 0.90
Surgical treatment of exercise-induced laryngeal dysfunction. Eur Arch Otorhinolaryngol (2007) 0.89
Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society. Eur Arch Otorhinolaryngol (2009) 0.89
Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life. Acta Otolaryngol (2005) 0.87
Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Acta Otolaryngol (2006) 0.86
Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: is dissection of sublevel IIB necessary? Oral Oncol (2007) 0.86
Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses. BMC Immunol (2011) 0.84
Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum. Eur Arch Otorhinolaryngol (2006) 0.84
European surgeons were the first to perform neck dissection. Laryngoscope (2007) 0.83
[Fish--more than just omega 3]. Tidsskr Nor Laegeforen (2006) 0.83
An optimized technique for separation of human decidual leukocytes for cellular and molecular analyses. Am J Reprod Immunol (2002) 0.82
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density. Acta Otolaryngol (2005) 0.80
Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol (2007) 0.80
Cross-cultural adaption and translation of the voice handicap index into Norwegian. Folia Phoniatr Logop (2012) 0.79
Laminin expression in advanced laryngeal squamous cell carcinoma does not correlate to neck metastases. Eur Arch Otorhinolaryngol (2008) 0.79
Mononuclear phagocytes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2009) 0.79
The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Otolaryngol (2014) 0.79
The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma. Acta Otolaryngol (2014) 0.78
Level of distress predicts subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Acta Otolaryngol (2013) 0.78
Multidisciplinary team a prerequisite in endoscopic endonasal skull base surgery. Eur Arch Otorhinolaryngol (2010) 0.77
Perioperative cytokine response to infection associated with elective arterial surgery. Vasc Endovascular Surg (2013) 0.77
Surgery and postoperative radiotherapy a valid treatment for advanced oropharyngeal carcinoma. Eur Arch Otorhinolaryngol (2010) 0.77
Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2006) 0.77
OK-432-stimulated chemokine secretion from human monocytes depends on MEK1/2, and involves p38 MAPK and NF-κB phosphorylation, in vitro. APMIS (2012) 0.77
In vitro cholesteatoma growth and secretion of cytokines. Acta Otolaryngol (2010) 0.77
Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine. BMC Pharmacol Toxicol (2013) 0.77
Prediction of 5 year survival from level of perceived distress in newly diagnosed head and neck squamous cell carcinoma patients. Oral Oncol (2013) 0.76
Personality traits in head and neck squamous cell carcinoma patients in relation to the disease state, disease extent and prognosis. Acta Otolaryngol (2002) 0.76
Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors. Eur Arch Otorhinolaryngol (2005) 0.76
Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue. Acta Otolaryngol (2007) 0.76
Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients. Eur Arch Otorhinolaryngol (2012) 0.76
Neck dissection in the nineteenth century. Eur Arch Otorhinolaryngol (2007) 0.75
Endoscopic endonasal sinus surgery: a review of 18 years of practice and long-term follow-up. Eur Arch Otorhinolaryngol (2006) 0.75
Concerning "The role of the CO2 laser in the management of laryngotracheal stenosis: a survey of 100 cases". Eur Arch Otorhinolaryngol (2005) 0.75
BVCP or PVCM? Eur Arch Otorhinolaryngol (2008) 0.75
Comment on "DNA ploidy in proliferative verrucous leukoplakia". Oral Oncol (2007) 0.75
Multidisciplinary team a prerequisite in the management of head and neck cancer? Eur Arch Otorhinolaryngol (2009) 0.75
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation. BMC Immunol (2009) 0.75
Larynx during exercise: the unexplored bottleneck of the airways. Eur Arch Otorhinolaryngol (2014) 0.75
The role of computed tomography in endoscopic sinus surgery: a review of 10 years' practice. Eur Arch Otorhinolaryngol (2006) 0.75
Quality of life, drinking to cope, alcohol consumption and smoking in successfully treated HNSCC patients. Acta Otolaryngol (2007) 0.75
In memoriam: Hans von Leden 1918-2014. Eur Arch Otorhinolaryngol (2014) 0.75
Risk factors and prognosis of anterior commissure versus posterior commissure T1-T2 glottic cancer. Ann Otol Rhinol Laryngol (2003) 0.75
The role of dendritic cells in the pharynx. Eur Arch Otorhinolaryngol (2003) 0.75
European Federation of Oto-Rhino-Laryngology Societies (EU.F.O.S.)--past, present and future. Otolaryngol Pol (2009) 0.75
Ultrasound of the abdomen and total bone scintigraphy in patients with cancer of the head and neck. Eur Arch Otorhinolaryngol (2005) 0.75
The Norwegian Voice Handicap Index (VHI-N) patient scores are dependent on voice-related disease group. Eur Arch Otorhinolaryngol (2015) 0.75
Organizing the future of European ORL. Acta Otolaryngol (2011) 0.75
The future of European Archives of Oto-Rhino-Laryngology and Head & Neck. Eur Arch Otorhinolaryngol (2008) 0.75